Ismail NAMBUNGA

Researcher at Ifakara Health Institute🇹🇿🇹🇿. Interested in understanding aquatic ecology and mating behaviors of malaria vectors

[Ismail NAMBUNGA @NambungaIsmail]

Surveillance doesn't pause 4 barriers. We move, adapt and conquer b'coz every delay risks lives #mosquitoes

[MESA - the malaria knowledge hub @MESAmalaria]

🦟🚫 Cabo Verde receives @WHO Malaria-Free certification!

This is a huge achievement for this island nation and provides a beacon of hope to other countries in Africa to pursue the elimination journey 💪

Read Cabo Verde's fascinating story
https://t.co/BIliGWrOdE

[Emmanuel Kaindoa @ekaindoa]

Just wrapped up an incredibly fruitful grant writing bootcamp with brilliant minds of @ihi.

[Fredros Okumu @Fredros_Inc]

Gay Mosquitoes 🦟?
~
Interesting observation this night from the VectorSphere at (@ifakarahealth) a few hours ago by my colleagues @EmmanuelHape & @Joel__D__Nkya . Context: Observations of the mating behaviour of some malaria mosquitoes. Two males copulating....
~
First I thought! Gay Mosquitoes?
~
Additional context below from the team:
~
"Its not end to end clasping of their male terminals but they went down the cage floor in copula" Emmanuel Hape

[Ifakara Health Institute @ifakarahealth]

BREAKTHROUGH:
WHO recommends for use malaria vaccine evaluated by Ifakara 💉

The @WHO has officially recommended for use a new malaria vaccine that @ifakarahealth was involved in conducting its clinical trials from 2021-2022 to prevent malaria infections in children. The @oxfordUni developed the vaccine in collaboration with the @SerumInstIndia.

In an updated advice on immunization published on its website yesterday, the @WHO recommends the R21/Matrix-M™ vaccine for the prevention of malaria in children. Both, @ifakarahealth Director @HonoratiM and Science Director @ally_olotu have lauded the breakthrough.

The recommendation follows advice from the @WHO: Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Group (MPAG) and was endorsed by the WHO Director-General following its regular biannual meeting held from September 25-29.

>> https://t.co/bPyXVJuZTA
>> #IFAKARAimpact #IFAKARAresearch #IFAKARAscience

[MalariaGEN @malariagenomics]

🗣️ "Anopheles funestus is a major malaria vector in sub-Saharan Africa known for its significant resistance to insecticides."

@joachimnwezeobi presents at #PAMCA2023 on how #genomics is exploring the population structure of this species across the continent.

[MalariaGEN @malariagenomics]

🗣️Fascinating #PAMCA2023 talk on insecticide resistance monitoring of Anopheles funestus mosquitoes in Tanzania 🇹🇿 🦟

@odero_joe stresses "the importance of having consistent data because you see how it changes over time. This species doesn't have that kind of data."

(Yet.)

[Ifakara Health Institute @ifakarahealth]

🦟🌍 PAMCA2023:
Ifakara walks “the zero-malaria” talk

The @pamcafrica conference in #Addis, Ethiopia 🇪🇹reached its third day, featuring a series of enlightening presentations.

Speakers included Dr. Sarah Moore who stressed the importance of enhanced insecticide testing for effective mosquito control, while @odero_joe emphasized the need to monitor and adapt to mosquito resistance. 🧬

As they look ahead to the conference's final day tomorrow, Ifakara's scientists remain dedicated to advancing comprehensive solutions for mosquito-borne diseases.🦠👩‍🔬🔬

>> https://t.co/g62NpHV872
>> #IFAKARAEvents #PAMCA2023

[Francesco Baldini @Baldini_Fra]

Mathematical modelers at #PAMCA2023
Imagine when all their neurons fire together 🤯 #leadership #modeling #vectorcontrol

[Fredros Okumu @Fredros_Inc]

Why we didn’t get a malaria vaccine sooner
https://t.co/PlzUvwdbz4 by @salonium et al

[Ifakara Health Institute @ifakarahealth]

#IASC2023 DAY 3️⃣:
Session on Mentorship and Career Development🌟

Distinguished panelists @Fredros_Inc, Dr. Wilson, Dr. Mtenga, Dr. Abdullah & @killeen_gerry shared invaluable insights on how scientists can grow professionally and compete on global platforms. 🌐📚

Each shared their own growth stories, encouraging the audiences; "Don't work alone, don't be afraid to ask for help from others who are more experienced, and remember to be self-motivated in your pursuits" - Dr. Sally Mtenga

Follow for more!
>> https://t.co/oGADDm4waJ
>> #IFAKARAevents #KT4HI #IAS2023

[Ifakara Health Institute @ifakarahealth]

#IASC2023 DAY 3️⃣:
Insights into leadership in science

@killeen_gerry gave a very engaging talk titled "The subtle art of herding cats: Cultivating cadres of expert leaders who are individually independent but nevertheless collaborate and learn together as effective teams."

>> https://t.co/oGADDm4waJ
>> #IFAKARAevents #KT4HI #IAS2023

[Ifakara Health Institute @ifakarahealth]

#IASC2023 DAY 3️⃣:
Vector control in Tanzania through the lens of gender!

Ampuriire Patience delved into the unique biological and cultural challenges faced by male and female scientists, she uncovered recommendations for inclusive scientific progress. 🌟

>> https://t.co/oGADDm4waJ
>> #IFAKARAevents #KT4HI #IAS2023

[Ifakara Health Institute @ifakarahealth]

#IASC2023 Day 2️⃣:
Engaging panel on malaria elimination!

@Fredros_Inc , Dr. Abdulla, @BishangaDr , Dr. Mwangoka & @patrickkachur sparked electric discussions on challenges and the path ahead. The panel weighed in on human-centered approaches to prevention and early detection tools and interventions, community empowerment, and multi-sectoral partnerships, towards achieving #ZeroMalaria transmissions in Tanzania! 🦟🔬

[Fredros Okumu @Fredros_Inc]

Ifakara and Oxford Scientists Describe a New Malaria Vaccine Candidate with Particularly Strong Immune Responses in African Infants.
~
RH5 is a potential antigen for a Plasmodium falciparum vaccine. A trial in Bagamoyo, Tanzania tested its safety and immunogenicity on adults, young children, and infants. The vaccinations were well received with no serious adverse events and triggered RH5-specific immune responses. Young children and infants had higher anti-RH5 serum responses than adults. Given its promising safety and immunogenicity profiles, especially in infants, further clinical development of the RH5-based vaccine for malaria protection in young African infants is supported. Excellent work led by my colleague, @AllyOlotu and team
~
Silk et al 2023 https://t.co/bzaaec2G3f @MedCellPress @AllyOlotu @UniofOxford and @ifakarahealth

[Ismail NAMBUNGA @NambungaIsmail]

@skymotto Hongera sana master

[eric ochomo @eochomo]

Your malaria risk increases with decrease in altitude, not abundance of larval habitats
https://t.co/WCYrRoXfTZ

[Fredros Okumu @Fredros_Inc]

A few years ago, we began testing these mosquito-repellent sandals with my friend @ras_sango, several other colleagues at @ifakarahealth and Prof. Alvaro Eiras' lab at @ufmg in Brazil;
~
Great technology, worth revisiting. Target was both travellers (and tourists) and locals

[Ismail NAMBUNGA @NambungaIsmail]

Our life 🇹🇿

[Ismail NAMBUNGA @NambungaIsmail]

@Fredros_Inc In the early 1950s, researchers did a great job in controlling the disease thus there is significant reduction. If we learn what they did in early 1950s, taking it into action plus additional efforts and commitments then I see more achivements in 2030/2040 compared to 1950s.